Xconomy's EXOME Presents: State of the Biotech Union
Event Information
Description
Life science research and healthcare are a nationwide conversation. Now, with the stunning election of Donald Trump, that conversation is rife with questions. The Obama White House has used major initiatives to push innovation in precision medicine and cancer. Will those programs continue under Trump? As a candidate, Trump seemed open to addressing drug prices. Will his administration and a GOP-led Congress see eye to eye? How will the U.S. respond to threats like Zika virus, which has spread to our shores?
Xconomy wants to talk about it all. Join National Biotechnology Editor Alex Lash in San Francisco on December 6 for a post-election exploration of the biggest health and biotechnology issues across the land. Topics will include the future of national health initiatives, the intersection of Big Data and healthcare, the looming presence of genetic modification, and our national response to infectious disease.
Confirmed Speakers:
- John Wilbanks, Chief Commons Officer, Sage Bionetworks
- Vijay Pande, General Partner, Andreessen Horowitz
- Peter Kuhn, Dean’s Professor of Biological Sciences; Professor of Medicine and Engineering, USC
- Jacob Corn, Scientific Director, Innovative Genomics Initiative, UC Berkeley
- Melanie Ott, Senior Investigator, Gladstone Institute of Virology and Immunology, UCSF
- Marcy Darnovsky, Executive Director, Center for Genomics and Society
- Camille Samuels, Partner, Venrock
- Duncan MacCannell, CSO, OAMD, Centers for Disease Control and Prevention
- Matthew Porteus, Associate Professor of Pediatrics (Stem Cell Transplantation), Stanford University
- Nima Farzan, CEO, PaxVax
- Jenny Rooke, Managing Director, 5 Prime Ventures
- Laurent Fischer, CEO, Tobira Therapeutics
- Aarif Khakoo, VP Research and San Francisco Site Head, Amgen
- Adams Dudley, Director, UCSF Center for Healthcare Value
Twitter:
@Xconomy
#xconbio
Schedule:
Registration: 12:30 - 1:30 pm
Program: 1:30 - 5:30 pm
Networking Reception: 5:30 - 6:30 pm
View the full agenda.
Registration Information:
Tickets are transferable but not refundable.
To inquire about press registration, email events@xconomy.com.
EVENT HOST
NATIONAL PARTNER
CHARTER UNDERWRITER
Biogen
UNDERWRITERS
BioCrossroads • Jacobs Global Buildings
TEVA Pharmaceuticals • Texas Medical Center
VENTURE CAPITAL MEMBERS
Avalon Ventures • ARCH Venture Partners
Launch Capital • Polaris Partners • Santé Ventures
SR One • Third Rock Ventures
LIFE SCIENCE MEMBERS
Acorda Therapeutics • Alnylam Pharmaceuticals
Arrowhead Pharmaceuticals • Bayer • Epizyme
Genocea Biosciences • Health Advances
Sarepta Therapeutics
Organizer Xconomy
Organizer of Xconomy's EXOME Presents: State of the Biotech Union
Xconomy is the authoritative voice for the life sciences, focusing on funding, partnerships, and technologies supporting research and development of novel therapeutics. Our independent editorial team delivers the latest news and analysis on the financials and innovations driving startups as they move from discovery and development toward commercialization. And our business-to-business events, award shows, webinars, and whitepapers keep entrepreneurs, investors, and scientists relevant and informed – while facilitating deep, valuable connections and collaborations across the ecosystem.
